---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-026773"
form_type: "8-K"
ticker: "BIAF"
cik: "0001712762"
company_name: "bioAffinity Technologies, Inc."
filed_at: "2026-06-02T12:30:28+00:00"
generated_at: "2026-06-02T12:36:47.766291+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# bioAffinity SAB webinar on CyPath Lung for early lung cancer detection on June 16

## Summary
- Society for Advanced Bronchoscopy hosts free webinar June 16, 7pm ET on CyPath Lung's role in early lung cancer detection.
- Panel includes med onc Vijay Gunuganti, thoracic surgeon Reginald Baptiste, interventional pulmonologist Sai Guda.
- CyPath Lung is a noninvasive sputum test using flow cytometry and AI; published trial: 92% sensitivity, 87% specificity, 99% NPV for nodules <20mm.
- Webinar to discuss real-world benefits: guiding surgery, reducing unnecessary procedures, supporting surveillance.
- CEO Maria Zannes notes collaboration with SAB to advance minimally invasive lung diagnostics.

## SEC filing metadata
- accession: 0001493152-26-026773
- form_type: 8-K
- ticker: BIAF
- cik: 0001712762
- company_name: bioAffinity Technologies, Inc.
- filed_at: 2026-06-02T12:30:28+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1712762/000149315226026773/0001493152-26-026773-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1712762/000149315226026773/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-026773
- JSON: https://secwatch.observer/filing/0001493152-26-026773.json
- Plain text: https://secwatch.observer/filing/0001493152-26-026773.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.